Literature DB >> 1854109

Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment.

M Krahn1, C D Naylor, A S Basinski, A S Detsky.   

Abstract

OBJECTIVE: To determine the point at which adverse quality-of-life effects engendered by an aggressive cholesterol-lowering strategy dictate the use of a less aggressive approach.
DESIGN: Decision analysis was used to compare the effects of the National Cholesterol Education Program (NCEP) guidelines, an aggressive program, with those of the Canadian Task Force on the Periodic Health Examination (CTF) guidelines, a more conservative program. Quality-adjusted life expectancy was calculated for a theoretical cohort of middle-aged men treated according to each program using Markov cohort analysis. MEASUREMENTS: Guidelines were applied to the population of the Lipid Research Clinics Coronary Primary Prevention Trial (LRC-CPPT), under the assumption that cholesterol levels had the distribution of the age- and sex-matched general population. Outcomes were calculated using a three-state (health, coronary heart disease, and death) Markov model. State transition probabilities were calculated using bivariate (age and cholesterol) proportional hazards and logistic regression functions. MAIN
RESULTS: The result was a "toss-up"; the number of expected quality-adjusted life years was similar for both programs at all time intervals, although the conservative program was consistently slightly favored. The result was very sensitive to the disutility of dietary therapy (threshold value, 0.0014 compared with the baseline estimate of 0.02) but was also affected by the time frame of the analysis and the rate at which adverse effects of treatment decline.
CONCLUSIONS: Even small disutilities associated with treatment may outweight the benefits of aggressive cholesterol-lowering strategies. Research should be directed toward measuring these disutilities and finding ways to reduce their size. Incorporation of the disutility of treatment into policy formulation may result in less interventionist and less costly policies.

Entities:  

Mesh:

Year:  1991        PMID: 1854109     DOI: 10.7326/0003-4819-115-4-248

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  [The periodic health examination: a comparison of United States and Canadian recommendations].

Authors:  Cléo Mavriplis; Guylène Thériault
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

2.  The relative merits of population-based and targeted prevention strategies.

Authors:  Donna M Zulman; Sandeep Vijan; Gilbert S Omenn; Rodney A Hayward
Journal:  Milbank Q       Date:  2008-12       Impact factor: 4.911

Review 3.  Barriers and bridges to evidence based clinical practice.

Authors:  B Haynes; A Haines
Journal:  BMJ       Date:  1998-07-25

Review 4.  The independent roles of diet and serum lipids in the 20th-century rise and decline of coronary heart disease mortality.

Authors:  R H Rosenman
Journal:  Integr Physiol Behav Sci       Date:  1993 Jan-Mar

5.  Initiating, conducting and maintaining guidelines development programs.

Authors:  R S Hayward; A Laupacis
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

6.  Bridges between health care research evidence and clinical practice.

Authors:  R B Haynes; R S Hayward; J Lomas
Journal:  J Am Med Inform Assoc       Date:  1995 Nov-Dec       Impact factor: 4.497

Review 7.  Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.

Authors:  T van der Weijden; J A Knottnerus; A J Ament; H E Stoffers; R P Grol
Journal:  J Epidemiol Community Health       Date:  1998-09       Impact factor: 3.710

Review 8.  Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-08-15       Impact factor: 8.262

9.  Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation.

Authors:  B A Kiberd; K K Jindal
Journal:  BMJ       Date:  1995-12-16

10.  Cholesterol-lowering therapy: what patients expect in return.

Authors:  W W Reed; J E Herbers; G L Noel
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.